The Motley Fool Investing Philosophy: We generally recommend investors buy shares of at least 25 stocks and hold them for at least 5 years. Learn More
| 1 Year | 5 Year | 5 Year Annualized | Since IPO | |
|---|---|---|---|---|
| COR | +40.17% | +252.92% | +28.69% | +14,731% |
| S&P | +15.06% | +95.03% | +14.29% | +1,233% |
AmerisourceBergen Corp. engages in the provision of pharmaceutical products and business solutions that improve access to care. It operates through the Pharmaceutical Distribution Services and Other segments. The Pharmaceutical Distribution Services segment distributes an offering of brand-name, specialty brand-name and generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to healthcare providers, including acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, and long-term care and alternate site pharmacies. The Other segment focuses on global commercialization services and animal health, and includes AmerisourceBergen Consulting Services ABCS, World Courier, and MWI. The company was founded by in Emil P. Martini in 1947 and is headquartered in Conshohocken, PA.
The Motley Fool analyzed 16 billionaire-led hedge funds to get an idea of their healthcare sector investment strategies.
| Q2 2025 | YOY Change | |
|---|---|---|
| Revenue | $80.66B | 8.7% |
| Gross Profit | $2.66B | 27.4% |
| Gross Margin | 3.30% | 0.5% |
| Market Cap | $58.12B | 29.3% |
| Market Cap / Employee | $1.26M | 0.0% |
| Employees | 46K | 0.0% |
| Net Income | $689.75M | 41.5% |
| EBITDA | $1.24B | 26.4% |
Currently no data to display
Currently no data to display.
Currently no data to display.
| Q2 2025 | YOY Change | |
|---|---|---|
| Net Cash | $2.28B | -33.3% |
| Accounts Receivable | $24.56B | 2.1% |
| Inventory | 20.1K | 10.0% |
| Q2 2025 | YOY Change | |
|---|---|---|
| Long Term Debt | $8.04B | 93.1% |
| Short Term Debt | $196.79M | -65.2% |
| Q2 2025 | YOY Change | |
|---|---|---|
| Return On Assets | 2.70% | -0.2% |
| Return On Invested Capital | -0.59% | 1.9% |
| Q2 2025 | YOY Change | |
|---|---|---|
| Free Cash Flow | -$73.97M | -103.1% |
| Operating Free Cash Flow | $109.25M | -95.6% |
| Metric | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | YoY Change |
|---|---|---|---|---|---|
| Price to Earnings | 29.99 | 31.97 | 32.27 | 30.85 | 26.12% |
| Price to Book | 47.93 | 67.81 | 237.92 | 57.37 | 38.33% |
| Price to Sales | 0.15 | 0.14 | 0.17 | 0.18 | 16.42% |
| Price to Tangible Book Value | -3.49 | -3.46 | -4.27 | -3.43 | -2.95% |
| Price to Free Cash Flow TTM | 13.19 | 17.27 | 17.22 | 82.33 | 186.59% |
| Enterprise Value to EBITDA | 49.54 | 45.57 | 47.10 | 52.13 | 10.07% |
| Free Cash Flow Yield | 7.6% | 5.8% | 5.8% | 1.2% | -65.11% |
| Return on Equity | 258.4% | 245.3% | 161.6% | 130.6% | -43.32% |
| Total Debt | $5.62B | $8.15B | $7.86B | $8.24B | 74.18% |
ABC earnings call for the period ending September 30, 2021.
ABC earnings call for the period ending June 30, 2021.
ABC earnings call for the period ending May 5, 2021.
ABC earnings call for the period ending December 31, 2020.
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.
